glp 1 lawsuit Lipsitz, Ponterio & Comerford Victoza Lawsuit [2026 Update] |

Among those, only semaglutide and liraglutide carry specific FDA approvals for obesity

They are primarily prescribed for managing chronic metabolic conditions like Type 2 diabetes and clinical obesity

What is the market outlook for weight-loss drugs

Notably, we recently demonstrated that HITI outperforms HDR in terms of knock-in efficacy for GFP gene at the Alb locus in mouse hepatocyte when using clinically relevant, lipid nanoparticle (LNP)-based deliver systems

10.1016/j.jclinane.2023.111091 [DOI] [PubMed] 23.Santos LB, Mizubuti GB, da Silva LM, Silveira SQ, Nersessian RSF, Abib ACV et al (2024) Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retrospective single center observational study